Jounce Therapeutics Inc Revenue per Employee (JNCE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Jounce Therapeutics inc   (NASDAQ: JNCE)
 

Jounce Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Jounce Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 656,000, above the company average.
Within the Healthcare sector Jounce Therapeutics inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Jounce Therapeutics Inc has 125 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JNCE Revenue per Employee (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 656,000 - - 202,944 215,256
JNCE's Total Ranking # # # # #
Seq. Revenue Change - - - - -

JNCE Company Profile >> Back to JNCE Efficiency Comparisons >> Compare JNCE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 1,343,568 $ 537,266 $ 53,872
(Sep 30 2019)   (Sep 30 2018)



Financial Statements
Jounce Therapeutics Inc 's Revenue MRQ $ 82 Millions Visit JNCE's Income Statement
Jounce Therapeutics Inc 's Revenues TTM $ 82 Millions Visit JNCE's aggregate revenue growth
What are JNCE's Sales? Visit JNCE's Sales by Segment




Other Ratios
Jounce Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
JNCE's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for JNCE's Competitors
Revenue per Employee for JNCE's Suppliers
Revenue per Employee for JNCE's Customers

You may also want to know
JNCE's Sales Growth Rates JNCE's Pe Price to earnings ratio JNCE's Receivables Turnover Ratio JNCE's Stock Quote
JNCE's Net Income Growth Rates JNCE's Ps Price to Sales ratio JNCE's Sales per Employee JNCE's Asset Turnover Ratio
JNCE's Net Margin JNCE's Pb Price to Book ratio JNCE's Financial Strength Ratios JNCE's Dividend Payout Ratio
Date modified: 2026-08-31T00:11:41+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2022Number of Employees Dec 31 2022
Kineta Inc   1,142,250.00 $ 4.569  Million 4 
Thorne Healthtech Inc   1,132,333.48 $ 228.731  Million 202 
Sarepta Therapeutics Inc   1,117,380.84 $ 933.013  Million 835 
Carlisle Companies Incorporated  1,117,271.19 $ 6,591.900  Million 5,900 
Privia Health Group Inc   1,106,574.23 $ 1,356.660  Million 1,226 
Integrated Biopharma Inc  1,069,620.00 $ 53.481  Million 50 
Harpoon Therapeutics Inc   1,063,833.33 $ 31.915  Million 30 
Aurinia Pharmaceuticals Inc   1,047,109.38 $ 134.030  Million 128 
Biolife Solutions Inc   1,043,606.45 $ 161.759  Million 155 
Imagenebio Inc   1,041,200.00 $ 15.618  Million 15 
Minerva Surgical Inc   1,026,408.16 $ 50.294  Million 49 
Supernus Pharmaceuticals inc   1,023,371.17 $ 667.238  Million 652 
Abbvie Inc   1,018,491.23 $ 58,054.000  Million 57,000 
Pharming Group N v   1,017,930.69 $ 205.622  Million 202 
Calliditas Therapeutics Ab  1,015,405.79 $ 86.309  Million 85 
Cano Health Inc   1,014,413.33 $ 2,738.916  Million 2,700 
Cerus Corporation  997,097.22 $ 287.164  Million 288 
Ginkgo Bioworks Holdings Inc   984,960.82 $ 477.706  Million 485 
Fortress Biotech Inc   971,064.10 $ 75.743  Million 78 
G1 Therapeutics Inc   932,745.45 $ 51.301  Million 55 
Lifevantage Corp  925,484.30 $ 206.383  Million 223 
Masimo Corp  924,954.55 $ 2,034.900  Million 2,200 
Nabriva Therapeutics Plc  923,375.00 $ 36.935  Million 40 
Progyny Inc   919,290.89 $ 786.913  Million 856 
Palvella Therapeutics Inc   893,172.41 $ 25.902  Million 29 
Abcellera Biologics Inc   863,743.77 $ 485.424  Million 562 
Intercure Ltd   863,742.22 $ 388.684  Million 450 
Xenetic Biosciences Inc   853,462.50 $ 1.707  Million 2 
Inari Medical Inc   852,157.78 $ 383.471  Million 450 
Axonics Inc   842,160.00 $ 273.702  Million 325 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.